Goal
Establish a comprehensive eye-healthcare platform from early diagnosis to effective treatment, ensuring global holistic care solutions.
Meet our Flagship Products
Unlock Our
Expertise
and Services
Reference
1. Conus V., Geiser M. A Review of Silent Substitution Devices for Melanopsin Stimulation in Humans. Photonics. 2020; 7(4):121
Reference
2. Evéquoz, G. et al. Maximum Possible Contrast Level for Silent Substitution: A Theoretical Model Applied to Melanopsin Stimulation. JOSA A. 2021; (9): 1312–1938
Reference
1. Ayoub T, Patel N. Age-related macular degeneration. J R Soc Med. 2009;102(2):56-61.
Reference
2. Vyawahare H, Shinde P. Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Cureus. 2022;14(9):e29583.
Reference
3. Gehrs K, A., et al. Age-related macular degeneration–emerging pathogenetic and therapeutic concepts. Ann Med. 2006;38(7):450-471.
Oculox's website contains product-related information restricted to healthcare
providers, as they pertain to medical devices for professional use only.
To meet the applicable regulations confirm your role.
At Oculox Technologies, we are dedicated to driving innovation in ophthalmology and revolutionizing treatment options for eye diseases. Together, we are redefining standards of care, ensuring a brighter future for us all.
Establish a comprehensive eye-healthcare platform from early diagnosis to effective treatment, ensuring global holistic care solutions.
A new device combining cutting-edge pupillometry and specific scotopic light stimuli to evaluate and support the diagnosis of early-onset retina and neuroretina disorders.
A clinical-stage therapeutic device utilizing advanced multi-mode laser therapy technology to offer an effective alternative for intermediate age-related macular degeneration (AMD).
*This content is accessible only to verified healthcare providers
Unlock Our
Expertise
and Services
Experience: 15 years of expertise in developing medical devices for the ophthalmology field
Know-How: Multi-disciplinary competencies ranging from physics, engineering, and translational sciences to clinical trials management, regulatory, and entrepreneurship
Collaboration: Close partnerships with professionals in various disciplines and with ophthalmologists in different clinical settings
Patient Impact: Our solutions aim to significantly influence the lives of patients positively
Headquartered in Muzzano, we are committed to pioneering innovation in ophthalmology.
Our mission is to develop advanced technology and products that redefine the standard of care for ocular diseases.
